Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chillin Mix Kratom is a consumer-facing brand specializing in the retail and distribution of kratom (Mitragyna speciosa) products. The company offers a variety of kratom strains in powder and capsule forms, marketed for their potential analgesic, stimulant, and sedative properties. While kratom contains alkaloids like mitragynine that interact with opioid receptors, the company operates in the dietary supplement and herbal wellness space rather than the regulated pharmaceutical industry. Their business model focuses on direct-to-consumer sales and providing information on different botanical blends for wellness support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chillin Mix Kratom.